Cargando…

Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery

Antimicrobial peptides (AMPs) can kill bacteria by disrupting their cytoplasmic membrane, which reduces the tendency of antibacterial resistance compared to conventional antibiotics. Their possible toxicity to human cells, however, limits their applicability. The combination of magnetically controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Turrina, Chiara, Cookman, Jennifer, Bellan, Riccardo, Song, Jiankang, Paar, Margret, Dankers, Patricia Y. W., Berensmeier, Sonja, Schwaminger, Sebastian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573039/
https://www.ncbi.nlm.nih.gov/pubmed/37834098
http://dx.doi.org/10.3390/ijms241914649
_version_ 1785120372946894848
author Turrina, Chiara
Cookman, Jennifer
Bellan, Riccardo
Song, Jiankang
Paar, Margret
Dankers, Patricia Y. W.
Berensmeier, Sonja
Schwaminger, Sebastian P.
author_facet Turrina, Chiara
Cookman, Jennifer
Bellan, Riccardo
Song, Jiankang
Paar, Margret
Dankers, Patricia Y. W.
Berensmeier, Sonja
Schwaminger, Sebastian P.
author_sort Turrina, Chiara
collection PubMed
description Antimicrobial peptides (AMPs) can kill bacteria by disrupting their cytoplasmic membrane, which reduces the tendency of antibacterial resistance compared to conventional antibiotics. Their possible toxicity to human cells, however, limits their applicability. The combination of magnetically controlled drug delivery and supramolecular engineering can help to reduce the dosage of AMPs, control the delivery, and improve their cytocompatibility. Lasioglossin III (LL) is a natural AMP form bee venom that is highly antimicrobial. Here, superparamagnetic iron oxide nanoparticles (IONs) with a supramolecular ureido-pyrimidinone (UPy) coating were investigated as a drug carrier for LL for a controlled delivery to a specific target. Binding to IONs can improve the antimicrobial activity of the peptide. Different transmission electron microscopy (TEM) techniques showed that the particles have a crystalline iron oxide core with a UPy shell and UPy fibers. Cytocompatibility and internalization experiments were carried out with two different cell types, phagocytic and nonphagocytic cells. The drug carrier system showed good cytocompatibility (>70%) with human kidney cells (HK-2) and concentration-dependent toxicity to macrophagic cells (THP-1). The particles were internalized by both cell types, giving them the potential for effective delivery of AMPs into mammalian cells. By self-assembly, the UPy-coated nanoparticles can bind UPy-functionalized LL (UPy-LL) highly efficiently (99%), leading to a drug loading of 0.68 g g(−1). The binding of UPy-LL on the supramolecular nanoparticle system increased its antimicrobial activity against E. coli (MIC 3.53 µM to 1.77 µM) and improved its cytocompatible dosage for HK-2 cells from 5.40 µM to 10.6 µM. The system showed higher cytotoxicity (5.4 µM) to the macrophages. The high drug loading, efficient binding, enhanced antimicrobial behavior, and reduced cytotoxicity makes ION@UPy-NH(2) an interesting drug carrier for AMPs. The combination with superparamagnetic IONs allows potential magnetically controlled drug delivery and reduced drug amount of the system to address intracellular infections or improve cancer treatment.
format Online
Article
Text
id pubmed-10573039
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105730392023-10-14 Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery Turrina, Chiara Cookman, Jennifer Bellan, Riccardo Song, Jiankang Paar, Margret Dankers, Patricia Y. W. Berensmeier, Sonja Schwaminger, Sebastian P. Int J Mol Sci Article Antimicrobial peptides (AMPs) can kill bacteria by disrupting their cytoplasmic membrane, which reduces the tendency of antibacterial resistance compared to conventional antibiotics. Their possible toxicity to human cells, however, limits their applicability. The combination of magnetically controlled drug delivery and supramolecular engineering can help to reduce the dosage of AMPs, control the delivery, and improve their cytocompatibility. Lasioglossin III (LL) is a natural AMP form bee venom that is highly antimicrobial. Here, superparamagnetic iron oxide nanoparticles (IONs) with a supramolecular ureido-pyrimidinone (UPy) coating were investigated as a drug carrier for LL for a controlled delivery to a specific target. Binding to IONs can improve the antimicrobial activity of the peptide. Different transmission electron microscopy (TEM) techniques showed that the particles have a crystalline iron oxide core with a UPy shell and UPy fibers. Cytocompatibility and internalization experiments were carried out with two different cell types, phagocytic and nonphagocytic cells. The drug carrier system showed good cytocompatibility (>70%) with human kidney cells (HK-2) and concentration-dependent toxicity to macrophagic cells (THP-1). The particles were internalized by both cell types, giving them the potential for effective delivery of AMPs into mammalian cells. By self-assembly, the UPy-coated nanoparticles can bind UPy-functionalized LL (UPy-LL) highly efficiently (99%), leading to a drug loading of 0.68 g g(−1). The binding of UPy-LL on the supramolecular nanoparticle system increased its antimicrobial activity against E. coli (MIC 3.53 µM to 1.77 µM) and improved its cytocompatible dosage for HK-2 cells from 5.40 µM to 10.6 µM. The system showed higher cytotoxicity (5.4 µM) to the macrophages. The high drug loading, efficient binding, enhanced antimicrobial behavior, and reduced cytotoxicity makes ION@UPy-NH(2) an interesting drug carrier for AMPs. The combination with superparamagnetic IONs allows potential magnetically controlled drug delivery and reduced drug amount of the system to address intracellular infections or improve cancer treatment. MDPI 2023-09-27 /pmc/articles/PMC10573039/ /pubmed/37834098 http://dx.doi.org/10.3390/ijms241914649 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Turrina, Chiara
Cookman, Jennifer
Bellan, Riccardo
Song, Jiankang
Paar, Margret
Dankers, Patricia Y. W.
Berensmeier, Sonja
Schwaminger, Sebastian P.
Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery
title Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery
title_full Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery
title_fullStr Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery
title_full_unstemmed Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery
title_short Iron Oxide Nanoparticles with Supramolecular Ureido-Pyrimidinone Coating for Antimicrobial Peptide Delivery
title_sort iron oxide nanoparticles with supramolecular ureido-pyrimidinone coating for antimicrobial peptide delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573039/
https://www.ncbi.nlm.nih.gov/pubmed/37834098
http://dx.doi.org/10.3390/ijms241914649
work_keys_str_mv AT turrinachiara ironoxidenanoparticleswithsupramolecularureidopyrimidinonecoatingforantimicrobialpeptidedelivery
AT cookmanjennifer ironoxidenanoparticleswithsupramolecularureidopyrimidinonecoatingforantimicrobialpeptidedelivery
AT bellanriccardo ironoxidenanoparticleswithsupramolecularureidopyrimidinonecoatingforantimicrobialpeptidedelivery
AT songjiankang ironoxidenanoparticleswithsupramolecularureidopyrimidinonecoatingforantimicrobialpeptidedelivery
AT paarmargret ironoxidenanoparticleswithsupramolecularureidopyrimidinonecoatingforantimicrobialpeptidedelivery
AT dankerspatriciayw ironoxidenanoparticleswithsupramolecularureidopyrimidinonecoatingforantimicrobialpeptidedelivery
AT berensmeiersonja ironoxidenanoparticleswithsupramolecularureidopyrimidinonecoatingforantimicrobialpeptidedelivery
AT schwamingersebastianp ironoxidenanoparticleswithsupramolecularureidopyrimidinonecoatingforantimicrobialpeptidedelivery